Investigating long-term effects of severe lung disease in children
Long Term Outcome of Severe Lung Disease in Childhood
This study looks at how severe lung disease affects children over time to help doctors better understand and manage their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 1 Day to 18 Years |
| Sex | All |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense) |
| Trial ID | NCT06455800 on ClinicalTrials.gov |
What this trial studies
This observational study aims to understand the long-term consequences of severe lung disease in children by registering patients aged 0-18 years at the HCA Children's Hospital. It will collect data on various parameters, including height, weight, lung function test results, and imaging diagnostics, during yearly follow-ups. The study seeks to identify prognostic markers that can predict outcomes for children with severe lung disease, thereby enhancing monitoring and management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 0-18 years diagnosed with severe lung disease.
Not a fit: Patients who do not provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding of lung disease prognosis in children, leading to better management and treatment strategies.
How similar studies have performed: While there is limited information on similar studies, the approach of investigating prognostic markers in pediatric lung diseases is valuable and has potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: severe lung disease - Exclusion Criteria: no informed consent \-
Where this trial is running
Odense
- Hans Christian Andersen Children's Hospital — Odense, Denmark (Recruiting)
Study contacts
- Principal investigator: Josefine Gradman, PhD — Odense University Hospital
- Study coordinator: Josefine Gradman, PhD
- Email: josefine.gradman@rsyd.dk
- Phone: 0045 29241375
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.